Results 131 to 140 of about 73,706 (315)

qbicsoftware/qbic-singularity-megSAP 1.0

open access: yes, 2017
The megSAP pipeline as a Singularity ...
Alexander Peltzer
core   +1 more source

Robust three-dimensional best-path phase-unwrapping algorithm that avoids singularity loops [PDF]

open access: yes, 2009
In this paper we propose a novel hybrid three-dimensional phase-unwrapping algorithm, which we refer to here as the three-dimensional best-path avoiding singularity loops (3DBPASL) algorithm.
Burton, David   +8 more
core   +1 more source

Algorithms in SINGULAR

open access: yesComput. Sci. J. Moldova, 1996
The author shows how to use SINGULAR to solve some problems of algebraic geometry. SINGULAR is a computer algebra system whose basic algorithms are variants of a general standard basis algorithm for general monomial orderings. There are several examples in the paper.
openaire   +4 more sources

Splitting of singularities

open access: yesJournal of the Mathematical Society of Japan, 2002
15 ...
JIANG, Guangfeng, TIBĂR, Mihai
openaire   +4 more sources

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Trans-Belief: Developing Artificial Intelligence NLP Model Capable of Religious-Belief-like Cognitive Processes for Expected Enhanced Cognitive Ability

open access: yesReligions
This paper investigates the possibility of developing artificial intelligence (AI) systems capable of exhibiting limited cognitive processes analogous to aspects of human religious belief.
Ido Dagan
doaj   +1 more source

Singularity categories and singular loci of certain quotient singularities

open access: yes
Let $V$ be a finite dimensional $k$-vector space, where $k$ is an algebraic closed field of characteristic zero. Let $G \subseteq \mathrm{SL}(V)$ be a finite abelian group, and denote by $S$ the $G$-invariant subring of the polynomial ring $k[V]$. It is shown that the singularity category $D_{sg}(S)$ recovers the reduced singular locus of $\mathrm{Spec}
Chen, Xiaojun, Zeng, Jieheng
openaire   +2 more sources

Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil

open access: yesMolecular Oncology, EarlyView.
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain   +10 more
wiley   +1 more source

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

open access: yesMolecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu   +10 more
wiley   +1 more source

Adaptor protein CIN85 potentiates the motility of osteosarcoma cells via the Akt/mTOR and MMP2‐COL3A1 axis

open access: yesMolecular Oncology, EarlyView.
CIN85 is highly expressed in osteosarcoma, particularly in metastatic lesions. Its overexpression increases cell migration and Matrigel invasion, while silencing CIN85 suppresses these behaviors. Transcriptome analysis shows that CIN85 regulates MMP2, COL3A1, and Akt/mTOR signaling. Targeting these pathways reverses CIN85‐induced motility, highlighting
Iryna Horak   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy